Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Postmarketing evaluation of Clozaril may lead to increased patient availability

May 19, 1998

Scios and Janssen to copromote Risperdal

May 18, 1998

European Commission approves Novartis' Exelon

May 18, 1998

Ondansetron suppresses spontaneous sleep apnea in rats

May 18, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

TheraTech and Astra announce collaborative development of new pain medication

May 14, 1998

Pharmacokinetic profile of GTS-21 studied in rats after parenteral, oral dosing

May 14, 1998

Myotrophin declared "potentially approvable" by FDA

May 14, 1998

Phase II clinical trial initiated for Neotrofin

May 14, 1998

Phase I clinical trial of novel analgesic to begin in Sweden

May 13, 1998

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...